Abstract:Non-invasive early diagnosis is of great significance in disease pathologic development and subsequent medical treatments, and microRNA (miRNA) detection has attracted critical attention in early cancer screening and diagnosis. High-throughput, sensitive, economic, and fast miRNA sensing platforms are necessary to realize the low-concentration miRNA detection in clinical diagnosis and biological studies. Here, we developed an attomolar-level ultrasensitive, rapid, and multiple-miRNA simultaneous detection platform enabled by nanomaterial locally assembled microfluidic biochips. This platform presents a large linear detection regime of 1 aM–10 nM, an ultralow detection limit of 0.146 aM with no amplification, a short detection time of 35 min with multiplex miRNA sensing capability, and a small sample volume consumption of 2 μL. The detection results of five miRNAs in real samples from breast cancer patients and healthy humans indicate its excellent capacity for practical applications in early cancer diagnosis. The proposed ultrasensitive, rapid, and multiple-miRNA detection microfluidic biochip platform is a universal miRNA detection approach and an important and valuable tool in early cancer screening and diagnosis as well as biological studies.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04896?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04896</a>.The supplementary data associated with this article can be found.Schematic fabrication process of a double-layer microfluidic biosensing chip; DNA probes and miRNA sequences used in this study; work principle flow of the nanomaterial locally assembled microfluidic biochip; TEM, XRD, Raman spectrum, and absorption spectrum of GO and Raman and absorption spectra of PLL; surface morphology of the glass slide and GO-assembled glass slide; GO Raman scanning results of different positions on the glass substrate; FAM fluorescence group on the DNA probe and Raman scanning results of different positions on the GO assembled on the glass substrate surface; design diagram of miRNA detection process verification; detection process parameters optimization; detection result of different disease miRNAs using the five DNA probes and single- and double-base mismatch miRNA; sensitivity detection result of different miRNAs; detection limit of the target miRNA; properties of different representative miRNA detection platforms; miRNA concentration of each sample in TE buffer corresponding to Figure S11; spiked miRNA concentrations in serum samples corresponding to Figure 5; detection of miRNA spiked in TE buffer; experimental results of spiked miRNAs in serum samples as listed in Table S5; recovery percent of the actual detection miRNA concentration in TE buffer and serum; actual miRNA detected concentrations and relative deviations of each sample in TE buffer corresponding to Figure S11d–h; relative deviation between the actual detection concentration and theoretical concentration spiked in serum corresponding to Figure 6b; detected fluorescence intensity of miRNA in healthy and patient serum; detected concentrations of the miRNA biomarkers in serum samples from healthy persons; and detected concentrations of the miRNA biomarkers in serum samples from breast cancer patients (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04896/suppl_file/ac0c04896_si_001.pdf">PDF</a>)Mechanism of the microfluidic chip (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04896/suppl_file/ac0c04896_si_002.mp4">MP4</a>)miRNA sensing principle of the microfluidic chip (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04896/suppl_file/ac0c04896_si_003.mp4">MP4</a>)This article has not yet been cited by other publications.

Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine

A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers

Integrated Microfluidic Systems with Sample Preparation and Nucleic Acid Amplification.

Microfluidic Chip Based Nucleic Acid Analyzer and Its Application in Precision Medicine

An Exploration of Nucleic Acid Liquid Biopsy Using a Glucose Meter.

The synergy of nucleic acid amplification and miniaturized systems in enhancing liquid biopsy applications

Prospects of Microfluidic Technology in Nucleic Acid Detection Approaches

Ultrafast and Highly Specific Detection of One-Base Mutated Cell-Free DNA at a Very Low Abundance

Ultrasensitive miRNA detection: A novel DNA nanomachine using split-type molecular beacons-mediated cascade amplification for cancer diagnostics

Liquid biopsy technologies based on membrane microfluidics: High‐yield purification and selective quantification of biomarkers in nanocarriers

DNA Framework-Mediated Electrochemical Biosensing Platform for Amplification-Free MicroRNA Analysis

Aptamer-Based Detection of Circulating Targets for Precision Medicine

Enzyme-assisted electrochemical point-of-care test for miRNA detection towards liquid biopsy application

Recent Advances in Integrated Microfluidics for Liquid Biopsies and Future Directions.

Microfluidic Technologies for cfDNA Isolation and Analysis

Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis

Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers

Integrated, DC Voltage-Driven Nucleic Acid Diagnostic Platform for Real Sample Analysis: Detection of Oral Cancer.

CRISPR/Cas13a-Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification-Free miRNA Diagnostics

Comprehensive detection of ctDNA variants at 0.1% allelic frequency using a broad targeted NGS panel for liquid biopsy research.

Attomolar-Level Ultrasensitive and Multiplex microRNA Detection Enabled by a Nanomaterial Locally Assembled Microfluidic Biochip for Cancer Diagnosis